Beam Therapeutics (NASDAQ:BEAM) outlined a new liver-targeted development program for phenylketonuria (PKU) and announced a large, non-dilutive financing tied to its sickle cell disease launch plans ...
Beam plans to utilize an 'umbrella' clinical trial design, allowing multiple mutation-specific base editors to be developed ...
Inovio Pharmaceuticals, Inc. ( INO) Oppenheimer 36th Annual Healthcare Life Sciences Conference February 25, 2026 12:40 PM EST ...
FDA Commissioner Marty Makary fielded questions Tuesday from Republican senators in a closed-door briefing on the abortion pill mifepristone.
Dose-escalating study will evaluate the safety, tolerability and exposure of STK-002 in people with ADOA––Changes in visual ...
Novartis today broke ground on a new, state-of-the-art global Biomedical Research center in San Diego, California, designed to provide world-class scientific infrastructure and drug-discovery ...
Chinese RNA-based medicine developer Suzhou Ribo Life Science has filed a Hong Kong IPO, aiming to raise new funds for its lead RBD4059 drug candidate for thrombotic diseases. The small-interfering ...
A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across ...
A proposed function of TADs is to contribute to gene regulation by promoting chromatin interactions within a TAD and by suppressing interactions between TADs. Here, we directly probe the ...
News-Medical.Net on MSN
Small RNA molecules can accurately predict survival in older adults
As people age, it becomes harder to know who is on track for healthy years ahead and who may be at higher risk for serious ...
Democrats sue the Trump administration over the CDC's recent changes to the U.S. childhood vaccine schedule. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results